0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Psychopharmacology

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Psychiatry
Original Investigation  | 
Prefrontal Cortical Dendritic Spine Pathology in Schizophrenia and Bipolar Disorder
Glenn T. Konopaske, MD; Nicholas Lange, DSc; Joseph T. Coyle, MD; et al.
JAMA Psychiatry
Original Investigation  | 
Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders:  Baseline Results From the RAISE-ETP Study
Christoph U. Correll, MD; Delbert G. Robinson, MD; Nina R. Schooler, PhD; et al.